PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

It makes up about 70% of all breast cancer cases. HR+/HER2- breast cancer involves tumor cells that test positive for hormone receptors and negative for HER2 proteins. Cancer cells with estrogen or ...

Relacorilant was well tolerated. Notably, there were no instances of drug-induced adrenal insufficiency, hypokalemia or QT ...

Patients who undergo a medication abortion during the first trimester of pregnancy are at a significantly higher risk of ...

Triple-positive breast cancer is a type of breast cancer that tests positive for estrogen receptors, progesterone receptors, and high levels of HER2 protein. Some types of breast cancer cells use ...

An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of.

For many women, finding out that they have breast cancer is the worst news they can receive. Even worse news is if the breast cancer is termed “triple-negative,” which is ...

It would be short-sided, erroneous and dangerous to think ill of mifepristone, which has several important applications,, M.D ...